Santander CIB Teams Up With Nephron Research for U.S. Expansion
Santander CIB has formed a strategic alliance with healthcare specialist Nephron Research LLC. This is the third such agreement for Santander in the U.S., following partnerships with Telsey Advisory Group LLC and Vertical Research Partners LLC. Nephron Research, founded by Lou Blessing, focuses on the healthcare sector, covering 84 companies across multiple sub-sectors.
Nephron Research, co-founded by Joshua Raskin and Eric Percher, will utilize Santander's global scale and financial market capabilities to enhance its reach and impact. Through this alliance, Santander will bolster its U.S.-based equity research offerings and gain access to Nephron's deep sector expertise.
David Hermer, Head of Santander CIB US, sees this alliance as a significant step in their U.S. growth strategy. It expands the insights and capabilities they can offer to clients. Both parties expressed excitement about the partnership, aiming to better serve their respective clients and unlock new avenues of mutual growth.
The alliance between Santander CIB and Nephron Research LLC is set to strengthen both parties' offerings. Nephron gains global reach and scale, while Santander expands its U.S.-based equity research capabilities. This strategic move underscores Santander's commitment to growing its U.S. presence and providing comprehensive services to its clients.
Read also:
- Trade Disputes Escalate: Trump Imposes Tariffs, India Retaliates; threatened boycott ranges from McDonald's, Coca-Cola to iPhones
- Aquatech purchases Koch's Direct Lithium Extraction business, merging Li-ProTM DLE technology into the PEARLTM Technology Platform.
- Nepal's Journey: Evolution from Street Life to Political Power
- Li Auto faces scrutiny after crash test involving i8 model and a truck manufacturer sparks controversy
